Our Experts will contact you providing a quote,
information and estimated timeframe to
your project needs.
Custom Models
-
-
-
-
-
-
-
-
-
-
-
-
-
- ● Diet-Induced Obesity (DIO) Mouse Model
- ● Type 1 Diabetes Mellitus (T1DM) Mouse Model
- ● Type 2 Diabetes Mellitus (T2DM) Mouse Model
- ● Diet-induced Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Mouse Model
- ● Chemically Induced Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Mouse Model
- ● Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Mouse Model (Gene-editing)
- ● Composite (Combined) Model - Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Model
- ● Composite Model - Atherosclerosis Mouse Model
- ● Atherosclerosis Mouse Model (Gene-editing)
- ● Acute Pancreatitis Mouse Model
- ● Chronic Pancreatitis Mouse Model
-
-
-
Testimonials
"I've been very happy with Cyagen's service so I've been referring a lot of colleagues... thanks for
the
great service."
'- Washington University in St. Louis
> more
> more
Citations
IMMUNITY 47:107 (2017) IF=22.845
Uox KO Mice
Product Number：C001232
Genetic Background：C57BL/6JCya
Reproduction：Homozygote x Homozygote
Strain Description
Uricase, which is encoded by the urate oxidase (UOX) gene, has an important role in the purine metabolic pathway, and most mammals contain UOX, which breaks down uric acid, a metabolite of purine nucleotides, into allantoin, which is more soluble than uric acid. Unlike other mammals, humans lack UOX, and purine catabolism can only produce uric acid, which is subsequently excreted by the kidneys, resulting in higher serum uric acid concentrations in humans than in other mammals. When the rate of uric acid production exceeds the excretory capacity of the kidneys, the serum uric acid level increases significantly, resulting in hyperuricemia.UOX can significantly reduce plasma uric acid levels and can treat gout and kidney disease secondary to hyperuricemia, among others[1].
This strain is a Uox gene deletion mouse, in which the synthesis of uricase is blocked in the mouse organism and the hyperuricemia phenotype occurs spontaneously. The heterozygous Uox KO mice are viable and fertile. This model was constructed by knocking out Exon 2~4 of the Uox gene. A similar strain is Uox-KO (Prolonged) (Catalog number: C001393. Exon 3~4 was deleted). Uox-KO (Prolonged) mice have milder symptoms of hyperuricemia after allopurinol treatment, longer lifespan, and higher survival rate in homozygotes. In contrast, the disease phenotype of Uox KO mice is more severe and the disease progresses faster.
The Uox gene is located on mouse chromosome 3, and Exon 2~4 of this gene was deleted.
The Uox KO mice can be used in the study of hyperuricemia, gout, and its related kidney disease.
Approximately 65% of homozygous Uox KO mice die successively after a few weeks of life and therefore need to be maintained after birth with drugs such as allopurinol[2].
1. The growth curve
Figure 1. The growth curve of homozygous Uox-/- mice. The mice were grouped
and given different concentrations of allopurinol, and their body weight was measured
weekly. The results showed that the trend of body weight change was similar in all groups
from 3-8 weeks with no significant difference; at 9-10W, the body weight of mice in the G3
group decreased and then remained unchanged.
(G1: Uox-/- mice + normal drinking, G2: Uox-/- mice + low dose allopurinol drinking, G3:
Uox-/- mice + medium dose allopurinol drinking, G4: Uox-/- mice + high dose allopurinol
drinking, G5: WT mice + normal drinking, Same below)
2. The survival curve
Figure 2. The survival curve of homozygous Uox-/- mice. Mice were grouped and given different concentrations of allopurinol, and survival status was monitored weekly. The results showed that the survival rate of Uox-/- mice in the G2 low-dose allopurinol group was always at 100%, while the survival rate of the other three groups started to decrease at 4 weeks. At the 10 weeks, the survival rates of the G1, G3, and G4 groups were 75%, 25%, and 25%, respectively.
3. Blood biochemical indices
Figure 3. The blood biochemical parameters of homozygous Uox-/- mice. The results showed that compared with wild-type mice in the G5 control group, Uox-/- mice in the G1 group showed hyperuricemia characterized by elevated levels of urea nitrogen (BUN), creatinine (CREA), and uric acid (UA) at 6 weeks and 8 weeks. Uox-/- mice fed allopurinol showed elevated levels of urea nitrogen, creatinine, and uric acid with increasing feeding concentrations, and elevation was more pronounced in female mice than in male mice.
The mice were fed with drinking water with 100 mg/L of allopurinol during both the gestation period of the mothers and the foster period of the offspring until the offspring were separated.
References
[1] Lu J , Dalbeth N, Yin H , et al. Mouse models for human hyperuricaemia: a critical review[J]. Nature Reviews Rheumatology, 2019, 15(Suppl. 10):1.
[2] Wu X . Hyperuricemia and urate nephropathy in urate oxidase-deficient mice[J]. Proc Natl Acad Sci U S A, 1994, 91.
